Intelligent Bio Solutions Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INBS research report →
Price Chart
About the company
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management.
- CEO
- Harry Simeonidis
- IPO
- 2020
- Employees
- 59
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on INBS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.21M
- P/E
- -0.17
- PEG
- -0.00
- P/S
- 1.24
- P/B
- 0.83
- EV/EBITDA
- -0.26
- Div Yield
- 0.00%
- Gross Margin
- 27.71%
- Op Margin
- -305.03%
- Net Margin
- -294.91%
- ROE
- -170.36%
- ROIC
- -179.58%
Latest fiscal year · YoY change
- Revenue
- $4.22M+38.1%
- Gross Profit
- $2.05M+64.4%
- Op Income
- $-12,608,085
- Net Income
- $-12,430,975-17.6%
- EPS
- $-8.44+57.8%
- OCF Growth
- -23.2%
- FCF Growth
- -21.6%
- 52W High
- $24.90
- 52W Low
- $1.52
- 50D MA
- $2.11
- 200D MA
- $3.85
- Beta
- 4.30
- RSI (14)
- 29
- Avg Volume
- 160.86K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the INBS Q1 '23 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 88.5%
- Shares Outstanding
- 3.32M
- Float Shares
- 2.94M
of shares held by institutions
9 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Cvi Holdings, LLC | 79.84K | ▼ 28.41K |
Held by 4 ETFs
Biggest fund positions in INBS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Boyages Steven Constantine | other | 5,000 |
| Mar 18, 26 | Fraser Nicola Marion | other | 5,000 |
| Mar 18, 26 | Sakiris Spiro Kevin | other | 21,350 |
| Mar 18, 26 | Sakiris Spiro Kevin | other | 9,150 |
| Mar 18, 26 | Hurd Jonathan Scott | other | 5,000 |
| Mar 18, 26 | Isenberg Jason | other | 5,000 |
| Mar 18, 26 | Simeonidis Harry | other | 21,350 |
| Mar 18, 26 | Simeonidis Harry | other | 9,150 |
| Sep 25, 24 | Simeonidis Harry | other | 40,000 |
| Sep 25, 24 | Sakiris Spiro Kevin | other | 34,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our INBS coverage
Recent articles, reports, and earnings notes.
No research on INBS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate INBS report →Intelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System Transcript
seekingalpha.com · Sep 24
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
globenewswire.com · Sep 10
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
globenewswire.com · Sep 9
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
globenewswire.com · Sep 1
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
globenewswire.com · Sep 1
BlackRock Inc. Invests $149.96 Million in Intelligent Bio Solutions Inc. $INBS
defenseworld.net · Aug 29
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
globenewswire.com · Aug 19
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?
benzinga.com · Aug 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.